RYKAX (RYKAX) Stock Price & Analysis
RYKAX (RYKAX) rose 1.28% to USD 108.14 as of June 10, 2026 at 21:07 UTC, according to Nexqual real-time market data.
RYKAX last closed at USD 106.77; the session ranged USD 108.14–108.14 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 86.32–111.73 (NAS). Source: Nexqual, June 10, 2026 at 21:07 UTC.
Key Statistics (as of June 10, 2026 at 21:07 UTC)
| Price | USD 108.14 |
|---|---|
| Change | ▲ 1.28% (up) |
| Previous Close | USD 106.77 |
| Open | USD 108.14 |
| Day Range | USD 108.14 – 108.14 |
| 52-Week Range | USD 86.32 – 111.73 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (RYKAX)
Nexqual's technical model rates RYKAX "BUY" based on 5 bullish and 1 bearish signals across 123 daily candles, as of June 10, 2026 at 21:07 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 59.13 (neutral) |
| vs SMA50 | Above (USD 104.59) |
| MACD | 0.76 (positive) |
Financial Health Score (RYKAX)
Nexqual rates RYKAX's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 21:07 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RYHAX | Rydex Series Fds, Health Care F | USD 115.74 | ▲ 1.83% |
| RYCAX | Rydex Series Fds, Consumer Prod | USD 93.71 | ▲ 1.67% |
| RYFAX | Rydex Series Fds, Financial Ser | USD 89.86 | ▲ 1.35% |
| RYOAX | Rydex Series Fds, Biotechnology | USD 61.79 | ▲ 1.73% |
| RYSAX | Rydex Series Fds, Electronics F | USD 859.14 | ▼ 1.57% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 21:07 UTC. This page is informational and not investment advice.